Abstract
Two hundred and thirty five patients with osteosarcoma, aged less than 40 years, and treated by amputation or radiotherapy, were entered in a randomised trial of two forms of adjuvant chemotherapy. A two drug regimen, namely vincristine 2 mg m-2 (maximum 2mg) followed by methotrexate 200 mgm-2, given every three weeks, was compared with a three drug regimen, comprising the same vincristine-methotrexate treatment, alternating every three weeks with doxorubicin 60 mg m-2. Both regimens were continued for 54 weeks. Forty-one patients were excluded, most because of inadequate histology, leaving 194 patients for analysis. One hundred and seventy of these had immediate amputation, 14 were treated by a policy of radiotherapy, with surgery delayed for 9 months, provided no distant metastases had appeared, and 10 by a policy of radiotherapy only. Patients have been followed-up for between 26 and 94 months after entry to the trial. The 2- and 5-year survival rates were 48% and 27%. No significant difference in survival was observed between the two regimens, but toxicity was less with the two drug regimen.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Consortia
Additional information
Members of the Working Party: R. Barnes (Chairman until February 1981), D.R. Sweetnam (Chairman since February 1981), N.M. Bleehen, J.M. Fitton, K.E. Halnan, K.A. Newton, W.M. Park (deceased), H.A. Sissons, H. Tate, J.A. Bullimore (Secretary since July 1983).
Rights and permissions
About this article
Cite this article
a report to the Medical Research Council by the their Working Party on Bone Sarcoma. A trial of chemotherapy in patients with osteosarcoma. Br J Cancer 53, 513–518 (1986). https://doi.org/10.1038/bjc.1986.81
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.81
This article is cited by
-
Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation
Scientific Reports (2020)
-
Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials
Journal of Orthopaedic Surgery and Research (2017)
-
The clinical efficacy of intra-arterial and systemic chemotherapy in the treatment of osteosarcoma of children
Journal of Orthopaedic Science (1996)